- ISIN
- CA67000B1040
- CUSIP
- 67000B104
- Sector
- Technology
- IPO Date
- Jan 4, 2016
Highlights
- Market Cap
- $6.41B
- Enterprise Value
- $6.34B
- EPS (TTM)
- $1.41
- PE Ratio
- 110.08
- PEG Ratio
- 30.70
- Total Revenue (TTM)
- $1.00B
- Gross Profit (TTM)
- $444.51M
- EBITDA (TTM)
- $150.84M
- Year Range
- $98.27 - $171.85
- Target Price
- $150.00
- ROA (TTM)
- 2.99%
- ROE (TTM)
- 4.10%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
NOVT Performance Chart
Novanta Inc. (NOVT) is up 30.8% since the beginning of the year. At $156 per share, NOVT is trading 9.4% below its 52-week high of $172. Investors who bought $1,000 worth of NOVT shares 5 years ago would now be looking at an investment worth $1,214.
Loading charts...
Returns By Period
Novanta Inc. (NOVT) has returned 30.82% so far this year and 29.11% over the past 12 months. Looking at the last ten years, NOVT has achieved an annualized return of 25.89%, outperforming the S&P 500 Index benchmark, which averaged 13.88% per year.
Novanta Inc.
- 1D
- 0.23%
- 1M
- -2.53%
- YTD
- 30.82%
- 6M
- 29.46%
- 1Y
- 29.11%
- 3Y*
- -2.65%
- 5Y*
- 3.95%
- 10Y*
- 25.89%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
NOVT Monthly Returns History
Based on dividend-adjusted daily data since Jan 4, 2016, NOVT's average daily return is +0.12%, while the average monthly return is +2.41%. At this rate, an investment would double in approximately 2.4 years.
Historically, 59% of months were positive and 41% were negative. The best month was Jul 2022 with a return of +27.2%, while the worst month was Jan 2022 at -21.7%. The longest winning streak lasted 19 consecutive months, and the longest losing streak was 8 months.
On a daily basis, NOVT closed higher 52% of trading days. The best single day was Nov 6, 2018 with a return of +19.6%, while the worst single day was Nov 6, 2025 at -19.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 13.07% | -0.08% | -12.14% | 9.67% | 23.01% | -2.30% | 30.82% | ||||||
| 2025 | -2.04% | -3.35% | -11.59% | -7.05% | 4.17% | 4.13% | -4.58% | -5.37% | -13.97% | 26.82% | -10.51% | 4.69% | -22.11% |
| 2024 | -8.23% | 11.90% | 1.06% | -10.45% | 3.62% | 0.59% | 11.08% | 1.16% | -2.38% | -4.85% | -1.91% | -8.51% | -9.29% |
| 2023 | 18.84% | -2.82% | 1.39% | -3.93% | 8.35% | 11.17% | -3.91% | -5.61% | -14.10% | -7.93% | 9.37% | 16.60% | 23.95% |
| 2022 | -21.68% | -1.06% | 4.14% | -9.55% | -4.46% | -1.37% | 27.15% | -13.30% | -13.49% | 22.27% | 11.56% | -13.87% | -22.95% |
| 2021 | 5.67% | 5.93% | -0.33% | -0.14% | 5.51% | -3.03% | 4.19% | 9.12% | 0.84% | 11.69% | -6.44% | 9.22% | 49.15% |
Benchmark Metrics
Novanta Inc. has an annualized alpha of 13.07%, beta of 1.33, and R2 of 0.38 versus S&P 500 Index. Calculated based on daily prices since January 04, 2016.
- This stock captured 182.57% of S&P 500 Index gains and 126.02% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.38 means the benchmark explains less than half of this stock's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 13.07%
- Beta
- 1.33
- R²
- 0.38
- Upside Capture
- 182.57%
- Downside Capture
- 126.02%
Return for Risk
Risk / Return Rank
NOVT ranks 61 for risk / return — better than 61% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Novanta Inc. (NOVT) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NOVT | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.44 | ||
| Sortino ratioReturn per unit of downside risk | -1.62 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.37 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 1.08 | 2.78 | -1.70 |
| Martin ratioReturn relative to average drawdown | 2.26 | 12.44 | -10.18 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Novanta Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Novanta Inc. was 46.71%, occurring on Nov 20, 2025. The portfolio has not yet recovered.
The current Novanta Inc. drawdown is 16.40%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 bear market2025 | -46.71%Nov 2025 | 1y 4mo | — | 1y 11moJul 2024 - now |
Bear market2022 | -38.60%Jun 2022 | 7mo 13d | 1y 13d | 1y 7moNov 2021 - Jun 2023 |
2023 bear market2023 | -34.98%Nov 2023 | 3mo 22d | 8mo 12d | 12mo 4dJul 2023 - Jul 2024 |
COVID crash2020 | -31.80%Apr 2020 | 1mo 19d | 1mo 17d | 3mo 6dFeb 2020 - May 2020 |
Rate-hike selloffLate 2018 | -27.81%Oct 2018 | 2mo 2d | 3mo 26d | 5mo 28dAug 2018 - Feb 2019 |
Drawdown Indicators
| NOVT | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.71% | -56.78% | +10.07% |
Max Drawdown (1Y)Largest decline over 1 year | -26.97% | -9.10% | -17.87% |
Max Drawdown (3Y)Largest decline over 3 years | -46.71% | -18.90% | -27.81% |
Max Drawdown (5Y)Largest decline over 5 years | -46.71% | -25.43% | -21.28% |
Max Drawdown (10Y)Largest decline over 10 years | -46.71% | -33.92% | -12.79% |
Current DrawdownCurrent decline from peak | -16.40% | -1.80% | -14.60% |
Average DrawdownAverage peak-to-trough decline | -12.30% | -10.71% | -1.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.90% | 2.03% | +10.87% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Novanta Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Novanta Inc. is priced in the market compared to other companies in the Scientific & Technical Instruments industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for NOVT, comparing it with other companies in the Scientific & Technical Instruments industry. Currently, NOVT has a P/E ratio of 110.1. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for NOVT compared to other companies in the Scientific & Technical Instruments industry. NOVT currently has a PEG ratio of 30.7. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NOVT relative to other companies in the Scientific & Technical Instruments industry. Currently, NOVT has a P/S ratio of 5.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NOVT in comparison with other companies in the Scientific & Technical Instruments industry. Currently, NOVT has a P/B value of 4.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with NOVT
Add Novanta Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with NOVT